Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Aristada is a prescription extended-release injectable antipsychotic containing aripiprazole lauroxil. It is approved for schizophrenia in adults. Aripiprazole lauroxil is converted in the body to aripiprazole. Aristada is given by intramuscular injection by a healthcare professional in monthly, every-six-week, or every-two-month schedules, depending on the selected dose.
read more about aristada ...After intramuscular injection, aripiprazole lauroxil is converted through enzyme-mediated hydrolysis into aripiprazole. Aripiprazole activity is thought to involve partial agonist effects at dopamine D2 and serotonin 5-HT1A receptors and antagonist effects at serotonin 5-HT2A receptors. The extended-release formulation maintains exposure between injections.
Aristada is approved for treatment of schizophrenia in adults. People who have not taken aripiprazole first establish tolerability with oral aripiprazole. Aristada is not approved for dementia-related psychosis. Dose selection is based partly on the oral aripiprazole dose that previously stabilized the patient.
Aristada is given by a healthcare professional. Initiation uses either one 675 mg Aristada Initio injection plus one 30 mg oral aripiprazole dose with the first Aristada injection, or 21 consecutive days of oral aripiprazole with the first injection. Aristada doses include 441 mg monthly, 662 mg monthly, 882 mg monthly or every six weeks, and 1064 mg every two months.
Aristada carries a boxed warning for increased mortality in elderly patients with dementia-related psychosis. Other serious risks include neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, compulsive behaviors, low blood pressure, falls, low white blood cell counts, seizures, and impaired judgment or movement. Weight, blood glucose, lipids, and movement symptoms need clinical monitoring.
Yes. Aristada is approved for treatment of schizophrenia in adults.
A healthcare professional administers each Aristada dose as an intramuscular injection.
Dosing schedules include once monthly, every six weeks, or every two months, depending on the prescribed strength.
No. Aristada Initio is a 675 mg initiation product used to start or restart Aristada treatment and is not used for repeated maintenance dosing.
ARISTADA (aripiprazole lauroxil) Prescribing Information. https://www.aristada.com/downloadables/ARISTADA-PI.pdf. Date Accessed September 14, 2026.
ARISTADA INITIO (aripiprazole lauroxil) Prescribing Information. https://www.aristada.com/downloadables/ARISTADA-INITIO-PI.pdf. Date Accessed September 14, 2026.
Aripiprazole Injection. MedlinePlus. https://medlineplus.gov/druginfo/meds/a615048.html. Date Accessed September 14, 2026.
DailyMed - ARISTADA (aripiprazole lauroxil) injection, suspension, extended release. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb. Date Accessed September 14, 2026.
FDA Label - ARISTADA (aripiprazole lauroxil) Extended-Release Injectable Suspension. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/207533s031lbl.pdf. Date Accessed September 14, 2026.